Bio-Techne Corporation
TECH
$54.41
$1.492.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.21B | 1.20B | 1.17B | 1.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.22B | 1.21B | 1.20B | 1.17B | 1.16B |
| Cost of Revenue | 408.52M | 403.75M | 400.67M | 395.05M | 385.26M |
| Gross Profit | 811.12M | 805.02M | 795.35M | 776.53M | 773.80M |
| SG&A Expenses | 446.71M | 489.08M | 447.37M | 434.32M | 430.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 954.73M | 981.04M | 940.85M | 920.09M | 906.11M |
| Operating Income | 264.91M | 227.73M | 255.16M | 251.49M | 252.95M |
| Income Before Tax | 98.46M | 162.98M | 185.79M | 176.30M | 185.69M |
| Income Tax Expenses | 25.06M | 31.32M | 27.66M | 25.59M | 17.59M |
| Earnings from Continuing Operations | 73.40 | 131.67 | 158.14 | 150.71 | 168.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.40M | 131.67M | 158.14M | 150.71M | 168.11M |
| EBIT | 264.91M | 227.73M | 255.16M | 251.49M | 252.95M |
| EBITDA | 374.81M | 338.58M | 365.75M | 362.80M | 364.66M |
| EPS Basic | 0.46 | 0.83 | 1.00 | 0.96 | 1.07 |
| Normalized Basic EPS | 1.04 | 0.87 | 0.95 | 0.94 | 0.92 |
| EPS Diluted | 0.45 | 0.83 | 1.00 | 0.95 | 1.05 |
| Normalized Diluted EPS | 1.03 | 0.85 | 0.94 | 0.92 | 0.90 |
| Average Basic Shares Outstanding | 629.25M | 632.20M | 632.14M | 631.24M | 630.84M |
| Average Diluted Shares Outstanding | 636.44M | 641.34M | 642.89M | 642.32M | 643.15M |
| Dividend Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 68.65% | 38.45% | 32.02% | 33.48% | 29.99% |